Stool DNA-based SDC2 Methylation Test for the Screening of Colorectal Neoplasia in an Asymptomatic, Average-Risk Population

Background/Aims: Programmatic screening for colorectal cancer (CRC) could maximize the impact of screening in the average-risk population, but the diagnostic performance of a stool DNA-based Syndecan-2 methylation (meSDC2) test has only been reported in case-control studies or high-risk populations....

Descripció completa

Dades bibliogràfiques

Autors principals:	Hyoung Il Choi, Jae Myung Cha, Young Sang Kim, Dae Hyeon Cho, Han Ju Pack, Soo-Young Na, Ji Hye Kim, Hyun Gun Kim, Young-Jin Park, Hye Jung Kwon, Kyeong Ok Kim, Geon Ho Lee, Yoo Jin Lee
Format:	Artigo
Idioma:	Inglês
Publicat:	Jin Publishing & Printing Co. 2026-01-01
Col·lecció:	The Korean Journal of Gastroenterology
Matèries:	biomarkers colorectal neoplasms dna methylation feces mass screening
Accés en línia:	https://www.kjg.or.kr/journal/view.html?pn=vol&uid=6165&vmd=Full&TG=vol&sm=&s_v=86&s_n=1&year=&
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!